Dissolution/drug release tests for parenteral products
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: STICKELMEYER, Mary (Eli Lilly and Company, Indianapolis, IN, United States of America)
Parenteral controlled release dosage forms are becoming more prevalent due to the fact that they can increase patient compliance, are capable of constant drug levels in vivo and thus offer improved therapeutic response for patients, and reduce the frequency for administration of the medication. Controlled release parenteral delivery systems.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.